We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
+85.23%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$71.2M
AUM Growth
-$59.4M
Cap. Flow
-$78.1M
Cap. Flow %
-109.8%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
1
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
TVRD
Tvardi Therapeutics
TVRD
+$7.42M

Top Sells

Rank Stock Value
1
IL
IntraLinks Holdings Inc.
IL
+$85M
2
MGNI icon
Magnite
MGNI
+$380K
3
SENS icon
Senseonics Holdings Inc
SENS
+$122K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Communication Services 0%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TVRD
1
Tvardi Therapeutics
TVRD
$24M
$65.6M 92.21%
99,113
+13,889
+16% +$7.42M
RCKT icon
2
Rocket Pharmaceuticals
RCKT
$351M
$5.26M 7.39%
656,948
– –
SENS icon
3
Senseonics Holdings Inc
SENS
$255M
$286K 0.4%
7,980
-2,537
-24% -$122K
MGNI icon
4
Magnite
MGNI
$2.57B
– –
-51,231
Closed -$380K
IL
5
DELISTED
IntraLinks Holdings Inc.
IL
– –
-6,290,503
Closed -$85M

Similar funds

LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

Rho Capital Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Rho Capital Partners held 5 positions worth $71.2M, down 45% from $131M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Rho Capital Partners withdrew a net $78.1M in Q1 2017, closing 2 positions and reducing 1 holding. Its most notable exit was IntraLinks Holdings Inc., an estimated $85M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 35% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Rho Capital Partners added an estimated $7.42M to Tvardi Therapeutics.

  • Rho Capital Partners added most to Tvardi Therapeutics in Q1 2017, an estimated $7.42M increase.
  • Rho Capital Partners's biggest Q1 2017 reduction was Senseonics Holdings Inc, cutting an estimated $122K.
  • Rho Capital Partners fully exited IntraLinks Holdings Inc. in Q1 2017, selling an estimated $85M.
  • Rho Capital Partners's ten largest holdings make up 100% of its $71.2M portfolio in Q1 2017.
  • Rho Capital Partners opened 0 new positions and closed 2 in Q1 2017.
  • Rho Capital Partners's portfolio value fell 45% quarter-over-quarter to $71.2M.

Based on Rho Capital Partners's 13F filing for Q1 2017, filed 4 May 2017.